C. Liwsrisakun, S. Pata, Witida Laopajon, Nuchjira Takheaw, Warawut Chaiwong, J. Inchai, C. Pothirat, C. Bumroongkit, Athavudh Deesomchok, Theerakorn Theerakittikul, Atikun Limsukon, P. Tajarernmuang, Nutchanok Niyatiwatchanchai, K. Trongtrakul, Kantinan Chuensirikulchai, W. Kasinrerk
{"title":"在先前接种过冠状病毒疫苗的老年人中,ChAdOx-1或BNT162b2增强后,对SARS-CoV-2变体的中和抗体和T细胞反应受到关注","authors":"C. Liwsrisakun, S. Pata, Witida Laopajon, Nuchjira Takheaw, Warawut Chaiwong, J. Inchai, C. Pothirat, C. Bumroongkit, Athavudh Deesomchok, Theerakorn Theerakittikul, Atikun Limsukon, P. Tajarernmuang, Nutchanok Niyatiwatchanchai, K. Trongtrakul, Kantinan Chuensirikulchai, W. Kasinrerk","doi":"10.1186/s12979-022-00279-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":367404,"journal":{"name":"Immunity & Ageing : I & A","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine\",\"authors\":\"C. Liwsrisakun, S. Pata, Witida Laopajon, Nuchjira Takheaw, Warawut Chaiwong, J. Inchai, C. Pothirat, C. Bumroongkit, Athavudh Deesomchok, Theerakorn Theerakittikul, Atikun Limsukon, P. Tajarernmuang, Nutchanok Niyatiwatchanchai, K. Trongtrakul, Kantinan Chuensirikulchai, W. Kasinrerk\",\"doi\":\"10.1186/s12979-022-00279-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":367404,\"journal\":{\"name\":\"Immunity & Ageing : I & A\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunity & Ageing : I & A\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s12979-022-00279-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity & Ageing : I & A","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12979-022-00279-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine